GEN Exclusives

More »

BioMarket Trends

More »
Sep 1, 2013 (Vol. 33, No. 15)

Top Biotech & Pharma Companies

  • Click Image To Enlarge +
    Annual Top 25 Biotechnology Companies

    As the global business environment continues to recover from the financial meltdown in 2008, biotech and pharma companies look like they are mending well. Indeed, as veteran bioindustry market guru G. Steven Burrill reported in July, there’s been a strong demand for life sciences IPOs this year. Through the first seven months of 2013, 29 life science companies raised a total of $5 billion on U.S. stock exchanges. This compares to 11 companies raising $771 million during the same period a year ago.

  • Earlier this year, Burrill pointed out that Big Biotech firms (e.g., Amgen, Gilead Sciences, Regeneron Pharmaceuticals, and Biogen Idec) have outpaced Big Pharma (e.g., Johnson & Johnson, Pfizer, Roche, Novartis, and Sanofi) in terms of growth of sales, income, and investment in R&D during the past three years.

  • Click Image To Enlarge +
    Annual Top 15 Pharmaceutical Firms

    “As the industry migrates away from an era of the one-size-fits all blockbuster, the biotechnology industry’s strength at developing innovative therapies that meet unmet medical needs and target the molecular mechanisms of diseases gives it an upper hand in creating value,” said Burrill, who serves as CEO of Burrill & Company, a global financial services firm. “But as pricing pressures become an increasingly challenging prospect for pharmaceutical and biotechnology companies alike, they will need to find new ways to build relationships with payers, providers, and patients to capture value outside of their products.”

  • But, as you can see from our two GEN listings—Top 25 Biotech Companies of 2013 and Top 15 Pharma Companies of 2013—the market caps of the leading firms in both sectors are healthy indeed. These numbers not only provide a reading on a company’s current value but hint at, not guarantee, a firm’s future performance.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?